Who owns Massachusetts stocks (part 1)
A brief look at the top institutional stockholders of the largest public companies in Massachusetts, ranked by market value, as of June 30 with help on the data from Bloomberg News:
1. EMC Corp.: Fidelity Investments became the largest EMC shareholder by June 30, though its sold 3 million shares during the quarter to reduce its holdings to 84.3 million shares, or 4 percent of the company. Capital Research & Management was the company's second largest investor with 75.4 million shares. Wellington Management, which had been EMC's largest stockholder, fell to third position by selling 110 million of its 176 million shares. EMC's big buyer during the second quarter was Lone Pine Capital, a hedge fund operated by Stephen Mandel, which acquired all its 47 million shares during the quarter to become the company's eighth-largest investor. Those purchases also made EMC the largest single investment in the Lone Pine portfolio.
2. State Street Corp: The big three of State Street investors remained intact during the second quarter, with a change in order. T. Rowe Price bought 2.4 million shares during the quarter to become the largest State Street holder. It owned 25.7 million shares on June 30, representing 6.6 percent of the company. Fidelity Investments, which added a minimal amount of stock during the quarter, was second with 24. million shares, or 6.3 percent of State Street. Wellington Management, a modest seller, was third with 23.1 million shares, or 5.9 percent.
3. Raytheon Co.: The three largest shareholders of Raytheon Co. remained in order during the second quarter. Fidelity Investments added 3.5 million shares during the quarter, for a total of 20 million shares or 4.6 percent of the company. Capital Research & Management was second with 3.5 percent of Raytheon's stock and Barclays Global Investors was third with a 3 percent interest.
4. Thermo Fisher Scientific: Goldman Sachs Group bought 6.3 million Thermo Fisher shares during the second quarter to become the company's largest holder with a total of 20.1 million shares. That amounts to an interest of 4.7 percent. Dodge & Cox, a modest seller during the quarter, was second with 18.3 million shares that represent 4.3 percent of the company. Fidelity Investments, which bought a limited amount of stock, was third with 14 million shares, amounting to 3.3 percent of the company.
5. Boston Scientific Corp.: Value-oriented investors were buyers of Boston Scientific shares during the second quarter. Dodge & Cox, which had owned no Boston Scientific stock at the end of the first quarter, bought 39.5 million shares by June 30 and Capital Research & Management nearly doubled its position by purchasing 22 million shares during the second quarter. The largest independent Boston Scientific shareholder (excluding the company's two founders) was Brandes Investment Partners, which added 16 million shares for a total of 78 million shares, or 5.2 percent of the company. Capital Research & Management was second with 51.1 million shares, or 3.4 percent and Franklin Resources was third with 50.6 million shares, or 3.4 percent. Wellington Management was a big seller of Boston Scientific stock during the second quarter, unloading its final 11.5 million shares. Wellington had made a much bigger bet on Boston Scientific stock that fizzled last year.
